AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Baird Medical Investment Holdings Limited
Video analysis: BDMD
All videosNo video analysis for this stock yet. Request one from our team.
News: BDMD
Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medical” or the “Company”) (Nasdaq: BDMD), a global medical technology company focused on the development and commercialization of minimally invasive treatment solutions, today announced that management will present at the H.C.
Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Revenue increase driven by significant growth in the United States and other strategic markets Revenue increase driven by significant growth in the United States and other strategic markets
Baird Medical Investment (NASDAQ:BDMD) Trading Down 2.5% – Should You Sell?
Shares of Baird Medical Investment Holdings Limited (NASDAQ: BDMD - Get Free Report) traded down 2.5% during trading on Thursday. The stock traded as low as $1.10 and last traded at $1.16. Approximately 78,671 shares traded hands during trading, an increase of 52% from the average session volume of 51,711 shares. The stock had previously
Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan (“DRAP”), further supporting the Company's commercial activities in the country.
Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”) and Tianjin Yuanshan Medical Technology Co., Ltd., operating under the Alpmed brand (“Alpmed”), a China-based innovator in irreversible electroporation (“IRE”) technology, announced the signing of a strategic cooperation agreement to establish a long-term partnership focused on global development and commercialization of next-generation IRE technologies.
Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina
First procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina.
